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ABSTRACT
Objective One in 20 women are affected by pre- eclampsia, 
a major cause of maternal and perinatal morbidity, death 
and premature birth worldwide. Diagnosis is made from 
monitoring blood pressure (BP) and urine and symptoms at 
antenatal visits after 20 weeks of pregnancy. There are no 
randomised data from contemporary trials to guide the efficacy 
of self- monitoring of BP (SMBP) in pregnancy. We explored the 
perspectives of maternity staff to understand the context and 
health system challenges to introducing and implementing 
SMBP in maternity care, ahead of undertaking a trial.
Design Exploratory study using a qualitative approach.
Setting Eight hospitals, English National Health Service.
Participants Obstetricians, community and hospital midwives, 
pharmacists, trainee doctors (n=147).
Methods Semi- structured interviews with site research 
team members and clinicians, interviews and focus group 
discussions. Rapid content and thematic analysis undertaken.
Results The main themes to emerge around SMBP include (1) 
different BP changes in pregnancy, (2) reliability and accuracy 
of BP monitoring, (3) anticipated impact of SMBP on women, 
(4) anticipated impact of SMBP on the antenatal care system, 
(5) caution, uncertainty and evidence, (6) concerns over action/
inaction and patient safety.
Conclusions The potential impact of SMBP on maternity 
services is profound although nuanced. While introducing 
SMBP does not reduce the responsibility clinicians have 
for women’s health, it may enhance the responsibilities 
and agency of pregnant women, and introduces a new set 
of relationships into maternity care. This is a new space 
for reconfiguration of roles, mutual expectations and the 
relationships between and responsibilities of healthcare 
providers and women.
Trial registration number NCT03334149.
INTRODUCTION
Raised blood pressure (BP) in pregnancy 
affects around 1 in 10 women, almost half of 
whom develop pre- eclampsia, a major cause of 
maternal and perinatal morbidity, death and 
premature birth worldwide.1 2 Diagnosis is made 
from monitoring BP and urine and symptoms at 
antenatal visits after 20 weeks of pregnancy.
Self- monitoring of BP (SMBP) in the general 
population has become more common and 
large trials have demonstrated its effectiveness in 
terms of BP control.3 Since the 2011 UK national 
guidance for the general population with hyper-
tension there has been a growing acceptance by 
clinicians of using SMBP values. Primary care 
physicians report an increasing use of SMBP 
to diagnose hypertension and for the ongoing 
management of hypertension to monitor BP 
control.4–7
But what are the implications of introducing 
SMBP for women during or after pregnancy, 
to improve the detection and management of 
gestational hypertension and pre- eclampsia? 
Pregnant women are different from the general 
population: BP can rise rapidly during pregnancy, 
and the problems associated with this (such as 
pre- eclampsia, eclampsia and stroke) are poten-
tially serious. Pilot work in the UK suggests, with 
support from midwives and doctors, it is feasible 
and acceptable for women to monitor their BP 
and urine safely, potentially identifying hyper-
tension earlier and controlling BP better.8–10 
SMBP during pregnancy is becoming common 
in some settings. A Canadian pilot study found 
Strengths and limitations of this study
 ► Qualitative study to explore maternity staff 
perspectives on self- monitoring of blood pressure in 
pregnancy.
 ► Diverse sample includes voices from across multi-
disciplinary maternity teams.
 ► Focus groups held across eight hospitals in the 
English National Health Services, including hospital 
and community midwives.
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more than 60% of women diagnosed with non- proteinuric 
hypertension in pregnancy were already undertaking SMBP.11 
The Society of Obstetricians and Gynaecologists of Canada 
provides guidelines for SMBP in pregnancy and most Cana-
dian obstetricians and primary care physicians used SMBP to 
assess for white coat hypertension (WCH),12 but its place in 
other countries is not yet clear.13
While SMBP in pregnancy is already implemented in some 
UK settings,14 there are no adequately powered randomised 
data from contemporary trials to guide the efficacy of such 
methods. Our early work exploring women’s experiences 
of taking part in an SMBP pilot study15 showed that most 
found their health professionals to be supportive, although 
in some cases self- monitoring results were ignored. An under-
standing of the attitudes of individuals and the organisation 
will be paramount in introducing new, and safe, models of 
care. Ahead of undertaking a large trial of BP monitoring in 
high- risk pregnancy to improve detection and monitoring of 
hypertension, we undertook a study to explore the perspec-
tives of staff across the maternity care pathway to explore the 
context and health system challenges to introducing and 
implementing SMBP in maternity care.10 16 17
METHODS
We carried out an intervention development phase in prepa-
ration for a large trial of SMBP in pregnancy, using qualita-
tive methods, with the aim of understanding the views and 
prior experience of clinicians regarding such monitoring. 
This involved interviews and focus groups across eight partic-
ipating teaching and urban general district hospitals that 
serve diverse populations (table 1). We conducted face- to- 
face interviews with a lead consultant obstetrician at each site 
(n=8) and a series of focus groups and interviews with a wide 
range of healthcare professionals.
Sample/setting
We sought a broad pragmatic sample that included commu-
nity and hospital- based midwives and obstetricians of 
different seniorities at each site (n=147). All focus groups and 
interviews took place at hospital or health centre sites, either 
as part of, or after, existing meetings or during shift breaks. 
It was usually a Research Midwife at each site who identified 
who might be available with some of the larger focus groups 
piggy- backing on existing meetings. Sampling was therefore 
convenience rather than purposive, though we ensured 
there was a representation of senior and junior obstetri-
cians, and hospital and community midwives from each site. 
Most participants had not previously engaged in studies on 
SMBP. Focus group size ranged from 2 to 15 individuals 
(see table 1). Some focus groups had a mix of obstetricians 
and midwives participating, reflecting the multidisciplinary 
teams providing care to women during pregnancy. Although 
an obstetrican is the lead clinician for almost all women 
with additional risk factors in pregnancy, the midwife is the 
conduit of care throughout pregnancy, labour and the post-
natal period.18
Data collection
The interviews and focus groups were facilitated by 
two experienced, post- doctoral social science/non- 
clinical researchers (LH and JH) and audio- recorded 
for transcription and analysis. A topic guide was devel-
oped drawing on the literature, our prior work and 
in discussion with the multidisciplinary trial team 
(see Topic Guide, online supplemental file). Ques-
tions sought to explore issues around staff views on 
SMBP in pregnancy, the accuracy of home readings, 
how to manage care of women who present with 
home readings (particularly those discordant with 
clinic readings), the impact of home readings on clin-
ical decision- making and workload, as well as prac-
tical issues around operationalising and integrating 
self- monitoring into current care pathways. Ethical 
approval and informed consent was obtained.
Analysis
All interviews and discussions were transcribed for 
analysis, which was conducted in two phases. An 
initial rapid analysis was undertaken to guide trial 
development.19 This used templates developed by JH 
and LH based on the topic guides and subsequently 
refined after a period of piloting. We conducted a 
rapid content analysis to identify evidence related 
to the a priori concepts and emergent themes that 
would then guide development of the study. This 
was discussed and refined with the wider research 
team. In a subsequent phase LH and JH, in discus-
sion with the wider team, developed a coding frame 
and worked in parallel (with LR) to code and analyse 
the data.20 Thematic analysis was undertaken to 
explore the anticipated and emergent themes and 
was then mapped back to the framework, supported 
by NVIVO.21 22 LH and JH met frequently to discuss 
the results together and then with the wider team 
to confirm the credibility and dependability of the 
analysis. Data collection continued until data satu-
ration was reached for the themes reported in this 
paper.23 Interviews and focus groups were analysed as 
a single dataset, reflecting the multidisciplinary teams 
providing care to women with additional risk factors 
in pregnancy. Results are presented as staff views, with 
illustrative quotes presented in table 2.
Patient and public involvement
This paper reports a substudy of a programme of 
intervention development work for the Blood pres-
sure monitoring in high- risk pregnancy to improve the 
detection and monitoring of hypertension (BUMP) 
trials.24 There was no direct patient involvement in the 
research reported here, as the focus was staff views and 
experiences. However, patient priorities were central 
to developing the trials and intervention development 
work reported elsewhere.25
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RESULTS
We heard views from a total of 147 healthcare profes-
sionals providing maternity care in the English 
National Health Service, of whom 37 were physicians 
(including principal investigators (PIs) and students) 
109 midwives and one pharmacist (see table 1). Our 
findings suggest SMBP during pregnancy was not 
yet a widespread practice across the sites included. 
Table 1 Study sample
Hospital Focus group Numbers Staff represented
Guy’s and St Thomas’ NHS Foundation Trust Focus group 1 10 Obstetricians, midwives, pharmacist
Focus group 2 4 Day assessment unit midwives
PI interview 1 Consultant obstetrician
West Middlesex University Hospital, Chelsea and Westminster 
Hospital, NHS Foundation Trust
Focus group 1 3 Midwives
Focus group 2 4 Midwives
Focus group 3 5 Midwives and obstetrician
Focus group 4 3 Midwives
PI interview 1 Consultant obstetrician
Whipps Cross Hospital, Barts Health NHS Trust Focus group 1 11 Obstetricians, midwives
Focus group 2 4 Antenatal midwives
Focus group 3 4 Day assessment unit midwives
PI interview 1 Consultant obstetrician
The Royal London Hospital, Barts Health NHS Trust Focus group 1 6 Community midwives (FMU)
Focus group 2 4 Community midwives (in hospital)
Interview 1 Consultant obstetrician
Focus group 3 7 Antenatal midwives
Focus group 4 2 Medical trainees
PI interview 1 Consultant obstetrician
John Radcliffe Hospital, Oxford University Hospitals NHS 
Foundation Trust
Focus group 1 11 Community midwives (in hospital)
Focus group 2 3 Obstetricians
Interview 1 Obstetrician
Interview 1 Consultant obstetrician
Interview 1 Obstetrician
Focus group 3 2 Hospital midwives (MAU)
Interview 1 Hospital midwife (MAU)
PI interview 1 Consultant Obstetrician
Horton General Hospital, Oxford University Hospitals NHS 
Foundation Trust
Focus group 4 13 Community midwives
Royal Berkshire NHS Foundation Trust Focus group 1 2 Hospital midwives
Focus group 2 2 Hospital midwives
Interview 1 Hospital midwife
Focus group 3 2 Obstetricians
Interview 1 Obstetrician
Focus group 4 6 Community midwives (in hospital)
PI interview 1 Consultant obstetrician
The Royal Wolverhampton NHS Trust Focus group 1 3 Obstetricians
Focus group 2 2 Hospital midwives
Focus group 3 10 Hospital and community midwives
Focus group 4 8 Hospital and community midwives
Interview 1 Hospital midwife
PI interview 1 Consultant obstetrician
Birmingham Women’s Hospital, Birmingham Women's and 
Children's NHS Foundation Trust
PI interview 1 Consultant obstetrician
Total 147
FMU, free- standing midwifery unit; MAU, maternity assessment unit; NHS, National Health Service; PI, principal investigator.







‘Even as midwives we get confused with what should be normal because we have a protocol that they have a booking [……measurement] 
so we’ve got a start and if it’s 15 either way for the diastolic and we have to sort of think well yes that’s creeping up a little bit if these girl’s 
sent them to me I would look at it and say well that’s not particularly high blood pressure because I’m dealing with PET all the time, you 
know, high blood pressure to me is 150/90 and above. So, isn’t it, it’s quite difficult and I think for a midwife let alone a woman to sit at 
home and think is that high am I going to be bothered’ Midwife
‘Another thing outside of pregnancy and not, most of what you’ll doing with hypertension monitoring is trying to prevent long term 
complications on a short term and therefore, actually what you, slightly over 24 hours probably is what really matters whereas in pregnancy 
[….] I’m actually only interested in whether or not they’ve got […] Well actually I’m really interested in the next 24 hours.’ Obstetrician
Wider symptoms
‘Yes but I think you raise a really important point about when you start to kind of focus on individual symptoms of a condition it’s, there’s 
a risk that you just focus on the blood pressure which means if you’re feeling dizzy or your ankles are puffy or you’re not really feeling 
yourself and got a blinding headache you don’t focus on any those things because the blood pressure says it’s okay.’ Community midwife
‘I think that they’re over checking their blood pressure and occasionally I think it is helpful that they see a midwife and do things like 
check the protein in the urine and things like that which, you know, occasionally perhaps not be able to manage quite so well yourself’ 
Obstetrician
‘So you kind of think oh are we only doing half of a job if they’re just monitoring their blood pressure’ Community Midwife
ii) Reliability and 
accuracy
‘As a health professional I know blood pressure’s affected by many things, whether you are taking it standing whether you are taking it lying 
whether it’s in the morning whether you, or you’ve just come back from Tesco with plastic bags and stuff like, you’re out of your breath or 
you’ve just fought with your partner or something like that, so many things influences blood pressure. So they will need to be given the 
empowerment they will need to take their blood pressure so that we, it’s as accurate as, so that we get as close to the normal if that can be 
achieved, something like that.’ Midwife
‘I wouldn’t ignore it if it was very elevated but I would certainly repeat it, I wouldn’t go with what they said… Because I’d be worried about 
the quality of their machine’ Obstetrician
‘We advise them not to because [um] they’re not calibrated, you know, they’re their own there’s no way they’re calibrated and also quite a 
lot of [um] blood pressure [um] equipment, we’ve read research that says it’s not as accurate as manual or a professional taking the blood 
pressure’ Midwife
‘When they come along and they bring readings [um] and they, if there’s any conflict and sometimes they don’t want to be labelled as 
hypertensive because it leads to certain choices later on in pregnancy that may be removed from them i.e. where they deliver, how they 
deliver [um] I then, you know, I will talk to them and say you, whatever you’re using at home may or may not be validated for pregnancy but 
what we use here is validated for pregnancy and therefore I would defer to those readings’ Obstetrician
‘I tend to be a little bit sceptical because you don’t know what they’re using, you don’t know what machine they’re using, you don’t know 
whether they’re trained to use it, you don’t know how old that machine is whether it’s again cuff size, you know, if they’ve borrowed it off 
somebody you don’t know whether it’s been PAT tested, you know, and if they are concerned about their reading being particularly high or 
particularly low I’d rather just get them in to see the relevant person at the time rather than rely on that, you know, I do worry about them 
using their own equipment because you just don’t know how accurate it is’ Midwife
iii) Impact on women ‘So for the women who have had severe pre- eclampsia in the past who are absolutely panic stricken about it being missed in the future 
[……] I don’t know scientifically if it matters but for them it gives them huge reassurance that they’ve got, it means that rather than 
them having to see the clinician every week or twice a week, they’re doing something, it’s rather like feeding a baby every other day.’ 
Obstetrician
‘There’s a lot of women that have mildly raised blood pressure that are fine, that we don’t really do anything with. [Um] and it’s a lot of 
monitoring for them’ Obstetrician
‘Some women might not want to monitor themselves because they wouldn’t feel, it will be too much responsibility in case they miss 
something’ Midwife
‘I think it’s a bit of mix isn’t it, I think some women would really like it saves them time especially if they’re busy they have other children.’ 
Midwife
‘I think a lot of women would also appreciate it because they often don’t want to come into hospital and they would, I think if they were 
self- monitoring at home if they’re taught in the right way and they know when somethings high or they know when to escalate or to ring 
and I think it will work really well and stop a lot of people coming in unnecessarily. I think it would be really good’ Midwife
iv) Anticipated impact 
on the antenatal care
‘We are so busy, we are too busy in hospitals and the more we can do out of hospital safely the better’ Obstetrician
‘There are benefits all- round aren’t there, if you’re, if we’re [um] happy that this woman is monitoring her blood pressure sensibly [um] it’s 
got benefits for her in that it means she doesn’t have to come so often, it’s got benefits for us in that it reduces our, our workload, surely 
it’s got, it has a, there’s an economic benefit there for the NHS [um] as a whole and it, I suppose that’s one of the things isn’t it that public 
health it’s about educating people isn’t it about, so that, you know, I think there are lots of benefits it’s [um] it’s just getting it in place. And 
being confident about the thing that you’ve got in place’ Midwife
‘I think it would have the potential to increase the appointments rather than decrease appointments as a screening tool for hypertension 
because of the worried well who’ve seen systolic increase in ten as an example but I don’t think it will decrease the routine ante- natal 
screening because that has many other roles including measurement of fundal height or foetal wellbeing.’ Medical trainee
‘I suppose potentially it will increase workload because people are going to recognise that they have a slightly elevated blood pressure 
sooner but I don’t think that’s necessarily a bad thing’ Obstetrician
‘So it’s a massive information imparting exercise probably more importantly than the, the systematic screening for obstetric complications 
that old fashioned people think of as ante- natal care. You know I, you know, again when I trained we’d see clinics of 40 people, 50 people 
in a morning where literally all you do would be check their blood pressure, check their urine, put your hand on their tummy, check their 
heart, you know, see if the patients still breathing, next, you know. But it isn’t like that now there’s a lot more education, seeing much more 
as a health education exercise as much as a screening for abnormality of pregnancy exercise.’ Obstetrician
Continued
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However, some midwives and obstetricians reported 
occasional pregnant women who were already self- 
monitoring, either of their own volition or because 
they had been advised to because of previous experi-
ences of pre- eclampsia, WCH, or pre- existing hyper-
tension. The main themes to emerge around SMBP 
were (1) different BP changes in pregnancy, (2) reli-
ability and accuracy of BP monitoring, (3) anticipated 
impact of SMBP on women, (4) anticipated impact 
of SMBP on the antenatal care system, (5) caution, 
uncertainty and evidence, (6) concerns over action/
inaction and patient safety.
Interpreting BP changes in pregnancy
BP fluctuation
Staff emphasised that BP is different in pregnancy than 
at other times in women’s lives. It fluctuates throughout 
pregnancy and these fluctuations are normal. However, 
BP in pregnancy can change rapidly, precipitating a 
medical emergency for mother and baby. While ante-
natal care staff will be familiar with this phenomenon 
through their training and experience, women may 
not be. There was concern women could have difficulty 
interpreting results and deciding when to seek acute 
care.
In the general population, BP readings are used to 
guide care and medication changes over the long term, 
but in pregnancy the situation is more dynamic. Some 
were interested in the wider context home BP read-
ings would give them, in particular, feeling women with 
WCH might get more typical readings at home. However, 
several indicated they would tend to privilege their own 
clinic readings as they reflected the situation happening 
immediately in front of them.
Wider symptoms
Staff were also concerned that BP is not the only factor in 
diagnosing hypertension or pre- eclampsia but rather one 
piece of a diagnostic ‘jigsaw’. Healthcare professionals 
stressed the importance of ensuring women were alert 
to the wide range of symptoms (eg, headaches, dizziness, 
blurred vision, proteinuria) and would act on those even 
if their BP appeared to be in the normal range.
Theme Quotations
v) Caution, uncertainty 
and evidence
Caution
‘I wouldn’t take the, take everything as a 100% as gospel because, you know, you can’t really it’s like triaging over the phone they can tell 
you so much but until you’ve seen that woman and made an assessment you can’t do a full assessment from that. But [um] but yes I mean 
it would certainly I, I like compare to a jigsaw puzzle, you know, putting all the pieces together that would definitely be one of the pieces I 
would definitely include once I knew that all the bits were safe that they were using and everything, yes.’ Midwife
‘If I look at it and I can see that yes at 2:00 ‘o’ clock and half two she had raised blood pressure but [….] guidelines about what I do about 
that [um] all I can do is do my own blood pressure readings and get them reviewed by the doctor. Unless there was like a real, you know, 
like a guideline of what we actually do about the trends, there’s not much I myself could actually do from it.’ Midwife
Uncertainty
‘I think that would be very useful information to have rather than as you say the snap shot that you get in clinic. Although on the opposite 
side if they were having consistently low readings at home and when they come and visit us in triage it’s always 160/110 I would question 
whether the data was true even if I knew that the machine was valid. Acknowledging the role of white coat hypertension but I would still be 
very worried about relying purely on the home readings and discarding the readings I have in the hospital.’ Medical trainee.
‘You can also have high blood pressure at home and lower blood pressure readings in hospital and we have no idea, I don’t think [um] 
what we should do when actually readings are different in different places and there is a tendency, there will be some people who will have 
a tendency to treat anybody whatever the excuse, much more common is a tendency to say oh it’s probably more, we’ve had 150, 140, 
120 I’m going to believe the normal whether its home reading or hospital readings. And so just having more data may just be making more 
noise rather than giving us, telling us what to do. But without the data we don’t even know if that’s true.’ Obstetrician
‘Supposed to be evidence based and when you actually look at them about 90% of the recommendations they make are expert opinion’ 
Obstetrician
vi) Concerns over 
action/inaction
‘Yes exactly and they may not realise the seriousness of it, so that would be my concern if they’re doing it at home. The chronic 
hypertension women have a lot of contact with, in hypertension clinic they understand blood pressure they’ve been dealing with it, they’re 
on medication they understand something about blood pressure, they might not fully understand how serious it can be with regards to pre- 
eclampsia but they certainly understand that they need to act on it and if they don’t, obviously it’s explained to them numerous times. My 
concern is if you did that to a general population will that message be translated.’ Midwife
‘I do have a worry about women taking, you know, something like pre- eclampsia is a multi- system disorder, blood pressure is one 
component and we see every week, every month women who come in with normal blood pressure but everything else going wrong and 
it would make me nervous about the idea of women taking control of their care so much so that they felt reassured by one reading and 
ignored their signs and symptoms and I think that, that will be, that’s a major, that’s a clinical worry that I have for using.’ Obstetrician
‘I think as long as they [women] understand the limits of what’s normal and what’s not and they know the right people to contact if not, 
then I don’t see there’s anything wrong with it’ Midwife
‘I just know that for some women they, they’ve got so much going on that actually their health is, is quite easily overlooked and [um] is last 
on the agenda if that makes sense and if they could miss a blood pressure reading here and there [um] then they may well do that and that 
would be my only [um] and which I feel awful saying really because I am so like passionate about actually women being responsible for 
their own care and taking ownership of it and us giving it back to them [um]. [……] I just think some women will be like oh yes, everything’s 
fine they’re all okay and maybe overlook things. I know you’ve got the opposite extent where some people would potentially act on it like 
say there’s a higher reading because they think it will be acted on and that sort of thing as well but I think you could almost get women who 
will either pretend they’ve done it or pretend that it’s an okay reading when it’s not [um] which is awful to say that we don’t trust women 
but’ Midwife
Table 2 Continued
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Reliability and accuracy
The reliability and accuracy of machines were key concerns 
for staff, as well as whether women would monitor their 
BP correctly and respond appropriately. Many raised 
concerns about the quality of home BP monitors, whether 
women were using one of the relatively few validated for 
use in pregnancy, and whether they were properly cali-
brated. There were concerns about appropriate cuff size, 
particularly for women with a high body mass index. 
Other factors identified as potentially impacting the reli-
ability and accuracy of home readings included women’s 
practices and the context in which they took readings 
(did they sit correctly, choose a quiet time of day?).
Views on the impact on women
Staff had a range of perceptions about how pregnant 
women might feel about being asked to self- monitor their 
BP. Some anticipated women being happy to participate 
and enjoying a sense of agency, control and reassurance 
over their own healthcare. Others raised concern that 
women may experience increased anxiety and become 
obsessed about their BP. Some felt pregnant women 
expect care to be led by providers and asking them to 
monitor their own BP would be perceived as a way of abdi-
cating responsibility. Although staff also acknowledged 
the potential for empowerment, some expressed concern 
that asking women to self- monitor would contribute to 
an over- medicalisation of pregnancy in contrast with 
the evolution of antenatal care away from this model in 
recent years.
Many potentially positive impacts for women were 
identified both in terms of quality of experience and 
better outcomes for mother and baby. These included 
fewer medical appointments, shorter waiting times and 
avoiding hospitalisation. Staff acknowledged detecting BP 
increases earlier would have the potential to deliver better 
outcomes for both mothers and babies, but confirmed 
definitive evidence of these outcomes would be needed 
before they could commit to changing their practice.
Anticipated impact on antenatal care
Staff were caught between feeling SMBP could reassure 
women, so cutting ‘worried well’ visits and/or raise anxi-
eties, thus increasing them. So, while they recognised 
other potential health system benefits including fewer 
women coming into clinic, thus freeing up clinic time 
in hospital and in community care, they also raised 
various concerns around the impact of SMBP on ante-
natal care pathways and their workload. These included 
a rise in phone calls to maternity assessment units and an 
increased demand for care, particularly from the ‘worried 
well’.
Staff were aware that, ahead of definitive trial results, 
these reflections were hypothetical. Their currently avail-
able best comparator was their experience with women’s 
self- monitoring for gestational diabetes, which is now 
quite common. Some described SMBP as a challenge 
to their professional roles, particularly for midwives, 
and part of wider changes towards increasing self- care 
and personal responsibility in health. One consultant 
described the shifting responsibilities in antenatal care, 
with health education now as much a part of routine care 
as systematic screening for obstetric complications.
Caution, uncertainty and evidence
While staff were generally open to looking at home BP 
readings, most were mindful the evidence was not yet 
available as to how to treat these readings in conjunction 
with clinic readings. Most felt they could only treat home 
readings as additional rather than as core information, 
not directing care decisions, but contributing extra detail 
to the ‘jigsaw’.
Caution
Many midwives said that if self- monitoring readings were 
discrepant with clinic readings, they would privilege the 
readings they had just taken themselves. Most added 
they would take into account the home readings, though 
exactly how would be considered on a case- by- case basis. 
Some would use them as part of improving understanding 
of the wider context, but use their clinic reading for the 
decision on whether to admit a woman to hospital. The 
home reading would not be used for treatment deci-
sions but could influence how often an obstetrician felt it 
necessary to see a woman.
Some acknowledged the potential of SMBP to iden-
tify WCH. But in several midwife discussions, consensus 
emerged on the side of caution, such as referring women 
onwards or taking bloods if only one type of reading 
(clinic or home) was high. Others referred to local proto-
cols and guidelines although this was often interpreted as 
needing to act on any higher reading, implying caution 
and a focus on patient safety, with fear of being consid-
ered negligent explicitly raised by one midwife.
Some said they verified home readings by testing the 
device used by women alongside their clinic monitor. 
Several midwives commented they would have to respect 
a woman’s readings, as to do otherwise could affect 
mutual trust.
Uncertainty
There was awareness that pre- eclampsia is a variable 
condition in which the speed of disease progression varies 
considerably. Some felt SMBP could significantly miti-
gate some of these uncertainties. One senior obstetrician 
specifically alluded to a potential advantage of SMBP being 
its ability to reduce uncertainty by enabling clinicians to 
make objective assessment of how accurate clinic readings 
are, clarifying who has WCH, assessing the effectiveness 
of treatment and standardising the various clinical envi-
ronments that women might be seen in. Yet others clearly 
feared SMBP could increase uncertainty (discrepancy in 
readings), and/or lead to overcaution and overtreatment 
on the part of less experienced colleagues.
Different approaches to managing hypertension in 
pregnancy also emerged. While some make judgements 
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on a case- by- case basis, privileging the extent of change 
from baseline, the wider context, and individualised path-
ways, and given that different hospitals may have their 
own guidelines, others described a practice defined by 
the National Institute for Health and Care Excellence 
guidelines and the use of thresholds as the defining guide 
in when to intervene.26
Evidence
Numerous staff raised the need for additional and 
improved evidence. One obstetrician observed that 
guidelines are supposed to be evidence based but 
recommendations are often made on expert opinion. A 
different senior obstetrician also suggested that people 
practise defensively, leading to many unnecessary blood 
tests being done because a greater number of healthcare 
professionals (midwives and junior doctors) are able to 
request the tests, and because when women have been 
told they may have pre- eclampsia, heightened anxiety 
leads to repeated checks for reassurance. Overall, there 
was a distinct lack of consensus, but with a clear wish from 
many for more evidence to reduce uncertainty.
Concerns over action/inaction
While a shift to SMBP is in keeping with wider trends 
towards self- care and personal responsibility, working 
through this new balance of responsibility for acting on 
readings was a cause for concern. Staff raised concerns 
about women not acting on readings, through either 
not realising they required urgent action, not wanting to 
bother busy staff or not wanting to be hospitalised. There 
were concerns about women ignoring problems, or being 
falsely reassured by one reading and ignoring the wider 
context. Many stressed the importance of women having 
a clear understanding of what they were supposed to do if 
their readings were high, with a clear pathway for women 
presenting with high BP based on home readings.
Many staff made comparisons with home monitoring 
of blood glucose in gestational diabetes, either as a useful 
precedent for SMBP or evidence of the challenges of 
women deliberately or inadvertently coming in with inac-
curate results.
Others expressed the view that it is hospital policy (as 
well as being the health professional’s view) that they 
would rather ask women to come in for comprehensive 
assessment than have the woman check her BP at home 
and decide not to come in.
DISCUSSION
Main findings
Antenatal care staff were generally in favour of asking 
women to monitor their own BP at home, but flagged 
concerns about the potential impacts on women and staff 
workload, the reliability and accuracy of readings and 
the need for clarity about how the information would be 
used by clinicians. Many emphasised the importance of 
ensuring women understood what to do in the event of 
readings that cause concern and provided examples of 
other situations where women had failed to act in acute 
situations because they did not understand the severity of 
the situation or rationalised away the need to seek medical 
attention. Some voiced concerns about women becoming 
either anxious or falsely reassured by self- monitoring. 
There was a feeling that SMBP might only be for a select 
few as it will require a shift in thinking about who takes 
responsibility for the woman’s health.
Many of the issues raised were specific to pregnancy. 
However, concerns about the potential for monitoring 
leading to anxiety may also exist for the general popula-
tion, though previous studies have not found evidence to 
support this.27 These could be intensified when there may 
be additional anxiety related to the effect of BP changes 
on the baby. Concerns about device accuracy were well 
founded as relatively few monitors on the market are vali-
dated in pregnancy.28 The need to consider more than just 
BP and the dynamic nature of BP in pregnancy as opposed 
to BP in the general population means that failure to act 
has the potential for devastating consequences for both 
woman and baby. Yet, resistance to medicalisation may be 
heightened in a previously healthy younger population of 
‘women’ as opposed to ‘patients’.29 Continuity of care is an 
ambition not always achieved in maternity care. The lack 
of an established relationship of trust between women/
patients and healthcare professionals that is typical of hyper-
tension management in primary care, further complicates 
the situation.30 Staff are therefore understandably cautious 
and uncertain, while also willing to see the potential for 
SMBP to reduce uncertainty and add usefully to available 
evidence.
Strengths and limitations
A strength of this study is the breadth of multidisciplinary 
voices across the maternity care pathway captured, span-
ning eight differently located hospitals in England. This has 
given rich insights into the potential challenges of intro-
ducing SMBP into maternity care from the perspectives of 
different disciplines and locales. Our two- stage approach 
to analysis, led by social scientists with expert clinical input 
from coauthors in obstetrics, midwifery and primary care, 
has also enhanced the interpretive strength of the findings. 
Limitations include the challenges of holding focus group 
discussions with busy professionals engaged with frontline 
care. These are vital perspectives to capture but there were 
inevitably challenges in terms of finding time and space for 
some focus group discussions.
There are several literatures to draw on in interpreting 
these results.
Responsibilisation
To date, measuring and monitoring women’s BP in preg-
nancy has been a central component of the healthcare 
professional’s role in antenatal care. To include women’s 
home readings into these care pathways represents a signif-
icant shift in the balance of responsibility. Emerging liter-
ature that explores the shifts and implications of health 
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‘responsibilisation’ are of relevance. Shifts in the balance 
of responsibility have the potential to disrupt long estab-
lished care pathways and can be experienced both posi-
tively as well as negatively as surveillance.31 Exploring the 
impacts of these shifts is a live issue in the sociological liter-
ature from studies of ‘park runs’ to HIV management,32 33 
and the relationships between social workers and vulner-
able youth.34 Drawing on work by Garrett, Liebenberg et al 
explored the impact of shifts in neo- liberal systems, where 
individuals are expected to manage their own risks and 
demonstrate self- care. ‘These shifts impact on the roles 
that health professionals play, from active management 
to encouraging/teaching of the skills of management’.35 
Newman et al's study of young people with HIV revealed 
narratives of responsibilisation that can give rise to contest 
between young people and their clinicians.33 In exploring 
the impact of telecare on the management of long term 
conditions, Rogers et al concluded ‘Indeed a paradox of the 
reliance and acceptance of telecare is the creation of new 
relationships and dependencies rather than the diminution 
of reliance envisaged by policy.’36 Our findings on clinician 
caution and concerns over inaction, indicate that these 
shifts in responsibility could have profound impacts that we 
need to be alive to as we further explore the impact of this 
work going forward.37
Impact on professional roles
A shift in responsibility for BP monitoring may also have 
an impact on professional roles and identity. Concern 
over these impacts ran through various themes we have 
reported, including impact on workload, caution and 
uncertainty and location of expertise. Task shifting is a key 
issue in many healthcare settings, but it does not emerge 
seamlessly as revealed in the literature.38–41 How SMBP 
impacts on these professional roles, and how professionals 
behave when there is a shift in the locus of responsibility will 
need to be the focus for future work.
Patient safety
While staff raised concerns about the impact of SMBP on 
patient safety, these concerns were expressed in the context 
of an emerging evidence base for SMBP.13 17 As this develops, 
we draw on evidence that points to the considerable scope 
for improving patient and family contributions to the detec-
tion and management of acute illness.42 Delayed recogni-
tion and treatment of conditions such as pneumonia and 
meningitis in childhood,43 pre‐eclampsia and reduced 
fetal movements during pregnancy and after childbirth44 45 
and heart disease and stroke in adulthood,46 47 contribute 
significantly to the mortality and morbidity burden. These 
conditions typically present with a time‐critical window for 
early recognition and response, and are associated with red 
flag signs and symptoms (such as breathlessness and pain) 
which can signify a serious underlying condition and act 
as potential markers to aid patient and family involvement 
in escalation of care. However, research has shown there 
are challenges to speaking up and raising safety alerts in 
maternity care and that organisation- focused efforts are 
required to improve staff responsiveness.48
CONCLUSIONS
We need to be mindful that the impact of SMBP 
on maternity services could be profound although 
nuanced. While its introduction will not reduce the 
responsibility clinicians have for women’s health, it 
promises to enhance the responsibilities and agency 
of women, and introduces a new set of relationships 
into maternity care. We cannot simply look to the 
literature and experiences of SMBP in other popula-
tions (eg, such as hypertension outside of pregnancy) 
because of the very nature of BP changes in pregnancy 
and because this is a healthy population, unless specif-
ically indicated otherwise. This is, then, a new space 
for reconfiguration of roles, mutual expectations, and 
the relationships between, and responsibilities of, 
healthcare providers and mothers.
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